Nader Motamedy
Founder & Managing Partner @ Safar Partners
Nader Motamedy is a Managing Partner at Safar Partners. Prior to founding Safar, and until January 1, 2018, Nader was Senior Founding Partner, Chairman, and CEO of Caspian Private Equity (“CPE”), with over $3 billion under management. He led the Investment Team and was a member of the Investment Committee and responsible for the strategic directionas well as the development and management of the firm. During 2018, Nader was Vice Chairman of the Board of Managers of CPE. Prior to and concurrent to that, until January 2012, Nader was a Founding Partner and member of the Board of Managers of Caspian Capital Management, LLC (“CCM”) which managed as much as $2.2 billion of alternative assets, including fixed income relative value portfolios and quantitative trading strategies. CCM also provided non-discretionary consulting on as much as $3 billion in structured products on funds of hedge fund programs. Nader began his investment career at Morgan Stanley in 1985 and worked at Prudential Securities and CDC Investment Management Corporation prior to founding CCM.Nader holds an MBA from Boston College and a BS in Mechanical Engineering from Boston University. He serves on various company and fund advisory boards. In addition to other community engagements, he is also actively involved in several youth assistance and development projects. Nader was instrumental in establishing the Paris St. Germain professional soccer team youth development program and its Foundation in the United States to help underprivileged youth achieve their athletic as well as academic potential. He is also a senior advisor to Inter Campus, the philanthropic arm of Inter Milan soccer team in New York as well as the Youri Djorkaeff Foundation. Nader is also the president of the Boston Children’s Fund.
- Total investments:
- 7
- Last investment:
- Lead investor:
- 43%
Last updated:
For AI agents: llms.txt
Industries Nader Motamedy invests in
Stages Nader Motamedy invests in
Countries Nader Motamedy invests in
Investment Focus
Industry
- Software 2 (29%)
- Clean Energy 2 (29%)
- Machine Learning 2 (29%)
- Artificial Intelligence 2 (29%)
- Water 1 (14%)
Stage
- Seed 2 (29%)
- Series B 1 (14%)
- Series E 1 (14%)
- Venture - Series Unknown 1 (14%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Gradiant
|
Gradiant is a solutions provider and developer of cleantech water projects for advanced water and wastewater treatment. They provide microelectronics, pharmaceuticals, food and beverage, lithium and key minerals, and renewable energy. | Series E / May 18, 2026 | |
Gelmedix
|
Gelmedix is a developer of a biomaterial platform to improve drug delivery for complicated ophthalmic treatment. The company's platform offers a single non-invasive gel patch that can be used as a drug-eluting sealant with tissue adhesion, tunable drug elution, and biocompatibility properties, thereby enabling healthcare providers to reducethe usage of drops which cause inconvenience to patients. | $13M / Seed / Feb 17, 2026 | |
Commonwealth Fusion Systems
|
Commonwealth Fusion Systems develops fusion energy systems using high-temperature superconducting (HTS) magnets to create compact tokamak reactors. It is building SPARC, a demonstration device designed to achieve net energy gain from fusion and laying the groundwork for ARC, a grid-connected fusion power plant targeting early 2030s operation. Thecompany partners with MIT and manufactures its HTS magnets and related components, applying peer-reviewed science in its firewalling of plasma and reactor engineering. It has introduced innovations like the PIT VIPER superconducting cable to support pulsed-power magnet systems and accelerate readiness for commercial fusion. | $863M / Series B / Aug 27, 2025 | |
Turing
|
Turing is a digital solutions provider that harnesses the power of AI to optimize asset performance across the entire water value chain. | $14M / Venture - Series Unknown / Feb 26, 2025 | |
Liquid AI
|
Building AGI, AI as Service, Generative AI | $37.5M / Seed / Dec 01, 2023 | |
|
Liquid AI
|
Building AGI, AI as Service, Generative AI | $5.6M / Seed / May 05, 2023 | |
|
Gelmedix
|
Gelmedix is a developer of a biomaterial platform to improve drug delivery for complicated ophthalmic treatment. The company's platform offers a single non-invasive gel patch that can be used as a drug-eluting sealant with tissue adhesion, tunable drug elution, and biocompatibility properties, thereby enabling healthcare providers to reducethe usage of drops which cause inconvenience to patients. | Seed / Mar 10, 2022 |
Co-Investors
About Safar Partners
Safar Partners is a seed- to growth-stage venture fund investing primarily in technology companies out of MIT, Harvard, and the University of Rochester. We invest in platform technologies in the cleantech and advanced materials, AI/IT and robotics, and life science/medical device areas.
Safar Partners Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Arunas Chesonis
Managing Partner & Investment Committee Member
|
|||
|
Nader Motamedy
Founder & Managing Partner
|
|||
Vera Schroeder
Associate
|
|||
2 more contacts available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Nader Motamedy invest in?
Nader Motamedy invests primarily in Software, Clean Energy and Machine Learning startups, most often at Seed and Series B stage. Most of the 7 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Nader Motamedy last invest?
The most recent investment recorded for Nader Motamedy closed in May 2026. Shizune tracks 7 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
